Carbonyl reductase 1, also known as
CBR1, is an
enzyme which in humans is encoded by the
CBR1 gene.
Function
Carbonyl reductase is one of several monomeric,
NADPH-dependent
oxidoreductases having wide specificity for carbonyl compounds. This enzyme is widely distributed in human tissues. Another carbonyl reductase gene,
CRB3, lies close to this gene on chromosome 21q. CBR1 metabolizes many toxic environmental
quinones and pharmacological relevant substrates such as the anticancer
doxorubicin.
Polymorphisms
Up-to-date two non-synonymous polymorphisms on
CBR1 have been identified. The
CBR1 V88I polymorphism encodes for a valine-to-isoleucin substitution at position 88 of the aminoacid chain. In vitro studies with recombinant proteins indicate that the CBR1 V88 isoform has a higher Vmax towards the substrates
menadione (vitamin K<sub>3</sub>) and
daunorubicin. Recent studies in human liver cytosols show that an untranslated polymorphism on the 3'UTR region of the
CBR1 gene (rs9024) is associated with higher levels of the cardiotoxic metabolite doxorubicinol.<ref...
Read More